(Q34332044)

1 August 2017

title

Exploring the role of mitochondrial UQCRB in angiogenesis using small molecules (English)

1 reference

1 August 2017

Hye Jin Jung

1

1 reference

1 August 2017

Ho Jeong Kwon

series ordinal

2

1 reference

1 August 2017

language of work or name

1 reference

1 May 2013

1 reference

1 August 2017

1 reference

1 August 2017

volume

9

1 reference

1 August 2017

issue

5

1 reference

1 August 2017

page(s)

930-939

1 reference

Chemical genetics: elucidating biological systems with small-molecule compounds

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1039%2FC3MB25426G

Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB25426G

Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB25426G

Angiogenesis-dependent diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB25426G

Angiogenesis in cancer and other diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB25426G

[Tumoral angiogenesis: physiopathology, prognostic value and therapeutic perspectives].

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB25426G

Angiogenesis: mechanistic insights, neovascular diseases, and therapeutic prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB25426G

Fundamental Concepts of the Angiogenic Process

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB25426G

VEGF as a key mediator of angiogenesis in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB25426G

VEGF receptor signalling - in control of vascular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB25426G

VEGF inhibitors in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB25426G

SKLB1002, a novel potent inhibitor of VEGF receptor 2 signaling, inhibits angiogenesis and tumor growth in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB25426G

Update on angiogenesis inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB25426G

Molecular mechanisms and clinical applications of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB25426G

Human endothelial gelatinases and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB25426G

Tumor-promoting phorbol esters induce angiogenesis in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB25426G

Identification of an Inhibitor of Neovascularization from Cartilage

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB25426G

Marimastat: the clinical development of a matrix metalloproteinase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB25426G

The anti-angiogenic agent fumagillin covalently binds and inhibits the methionine aminopeptidase, MetAP-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB25426G

MetAP-2 inhibitors based on the fumagillin structure. Side-chain modification and ring-substituted analogues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB25426G

TNP-470: an angiogenesis inhibitor in clinical development for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB25426G

Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB25426G

Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB25426G

Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB25426G

Evaluation of HIF-1 inhibitors as anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB25426G

The hypoxia-inducible factor-1 alpha is a negative factor for tumor therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB25426G

Nuclear histone acetylases and deacetylases and transcriptional regulation: HATs off to HDACs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB25426G

Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB25426G

Inhibition of hypoxia-induced angiogenesis by FK228, a specific histone deacetylase inhibitor, via suppression of HIF-1alpha activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB25426G

Histone deacetylase inhibitors repress the transactivation potential of hypoxia-inducible factors independently of direct acetylation of HIF-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB25426G

Targeted cancer therapy: giving histone deacetylase inhibitors all they need to succeed

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB25426G

Histone deacetylase (HDAC) inhibitors in recent clinical trials for cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB25426G

Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB25426G

Hsp90 regulates a von Hippel Lindau-independent hypoxia-inducible factor-1 alpha-degradative pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB25426G

RACK1 competes with HSP90 for binding to HIF-1alpha and is required for O(2)-independent and HSP90 inhibitor-induced degradation of HIF-1alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB25426G

Calmodulin Plays a Pivotal Role in Cellular Regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB25426G

Calmodulin--an intracellular calcium receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB25426G

Ca2+/calmodulin kinase-dependent activation of hypoxia inducible factor 1 transcriptional activity in cells subjected to intermittent hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB25426G

Calcineurin promotes hypoxia-inducible factor 1alpha expression by dephosphorylating RACK1 and blocking RACK1 dimerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB25426G

Role of ERK and calcium in the hypoxia-induced activation of HIF-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB25426G

A novel Ca2+/calmodulin antagonist HBC inhibits angiogenesis and down-regulates hypoxia-inducible factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB25426G

Interaction of endostatin with integrins implicated in angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB25426G

Angiostatin binds ATP synthase on the surface of human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB25426G

Hypoxia-inducible factor 1alpha and antiangiogenic activity of farnesyltransferase inhibitor SCH66336 in human aerodigestive tract cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB25426G

Prostaglandin E2 induces hypoxia-inducible factor-1alpha stabilization and nuclear localization in a human prostate cancer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB25426G

Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB25426G

Phase II study of SU5416--a small-molecule, vascular endothelial growth factor tyrosine-kinase receptor inhibitor--in patients with refractory myeloproliferative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB25426G

Angiogenesis inhibitors: current strategies and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB25426G

The influence of natural products upon drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB25426G

Chemistry. The renaissance of natural products as drug candidates

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB25426G

Identification and validation of bioactive small molecule target through phenotypic screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB25426G

Enantioselective synthesis of (-)-terpestacin and (-)-fusaproliferin: clarification of optical rotational measurements and absolute configurational assignments establishes a homochiral structural series

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB25426G

Rapid identification of a protein binding partner for the marine natural product kahalalide F by using reverse chemical proteomics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB25426G

A new curcumin derivative, HBC, interferes with the cell cycle progression of colon cancer cells via antagonization of the Ca2+/calmodulin function

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB25426G

Identification and validation of calmodulin as a binding protein of an anti-proliferative small molecule 3,4-dihydroisoquinolinium salt.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB25426G

Display cloning: functional identification of natural product receptors using cDNA-phage display

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB25426G

Terpestacin inhibits tumor angiogenesis by targeting UQCRB of mitochondrial complex III and suppressing hypoxia-induced reactive oxygen species production and cellular oxygen sensing

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB25426G

Structure and function of cytochrome bc complexes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB25426G

Large scale domain movement in cytochrome bc(1): a new device for electron transfer in proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB25426G

Cloning and sequencing of a cDNA for human mitochondrial ubiquinone-binding protein of complex III

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB25426G

Isolation and characterisation of the linked genes APA2 and QCR7, coding for Ap4A phosphorylase II and the 14 kDa subunit VII of the mitochondrial bc1-complex in the yeast Kluyveromyces lactis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB25426G

The C-terminus of the 14-kDa subunit of ubiquinol-cytochrome-c oxidoreductase of the yeast Saccharomyces cerevisiae is involved in the assembly of a functional enzyme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB25426G

Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB25426G

Mitochondrial reactive oxygen species trigger hypoxia-induced transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB25426G

Oxygen sensing requires mitochondrial ROS but not oxidative phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB25426G

A chemical genomics screen highlights the essential role of mitochondria in HIF-1 regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB25426G

Synthesis enables identification of the cellular target of leucascandrolide A and neopeltolide

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB25426G

Membrane potential greatly enhances superoxide generation by the cytochrome bc1 complex reconstituted into phospholipid vesicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB25426G

Gene expression profiling reveals potential biomarkers of human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB25426G

Identification of tumor suppressors and oncogenes from genomic and epigenetic features in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB25426G

Genome-wide analysis of pancreatic cancer using microarray-based techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB25426G

Polymorphisms in the mitochondrial oxidative phosphorylation chain genes as prognostic markers for colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB25426G

Chemical genetics for therapeutic target mining

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB25426G

Identification of a novel small molecule targeting UQCRB of mitochondrial complex III and its anti-angiogenic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB25426G

Cross talk between mitochondria and NADPH oxidases

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3MB25426G

Terpestacin, a new syncytium formation inhibitor from Arthrinium sp.

21 January 2018

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.46.367

Identifiers

DOI

10.1039/C3MB25426G

1 reference

1 August 2017

1 reference